Impella ECP Pivotal Study Demonstrates Safety, Efficacy for Use in High-Risk PCI
Press Releases
Johnson & Johnson MedTech  
October 28, 2024

Impella ECP Pivotal Study Demonstrates Safety, Efficacy for Use in High-Risk PCI

DANVERS, Mass., Oct. 28, 2024 /PRNewswire/ -- Results were presented at Transcatheter Cardiovascular Therapeutics (TCT) 2024 conference from the first completed pivotal trial on patients supported with Impella ECP™, a

avatar profile Olean Times Herald

Olean Times Herald


Local & Social